Traci Lyons
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 22 | 2024 | 1872 | 4.040 |
Why?
| Semaphorins | 6 | 2021 | 21 | 3.390 |
Why?
| Antigens, CD | 7 | 2021 | 442 | 3.010 |
Why?
| Postpartum Period | 11 | 2022 | 281 | 2.470 |
Why?
| Cyclooxygenase 2 | 6 | 2020 | 164 | 2.180 |
Why?
| Lymphatic Vessels | 5 | 2024 | 54 | 1.990 |
Why?
| Mammary Glands, Human | 5 | 2024 | 60 | 1.880 |
Why?
| Mammary Glands, Animal | 7 | 2022 | 116 | 1.730 |
Why?
| Breast | 5 | 2022 | 138 | 1.290 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2022 | 1147 | 1.130 |
Why?
| Epithelial Cells | 4 | 2024 | 961 | 1.110 |
Why?
| Lymphangiogenesis | 4 | 2024 | 24 | 1.000 |
Why?
| Macrophages | 4 | 2020 | 1284 | 0.890 |
Why?
| GPI-Linked Proteins | 6 | 2021 | 54 | 0.880 |
Why?
| Tumor Microenvironment | 8 | 2022 | 431 | 0.850 |
Why?
| Receptors, Estrogen | 3 | 2021 | 372 | 0.800 |
Why?
| Puerperal Disorders | 2 | 2014 | 31 | 0.790 |
Why?
| Anoikis | 1 | 2021 | 31 | 0.780 |
Why?
| Mammary Neoplasms, Animal | 3 | 2016 | 28 | 0.760 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2020 | 139 | 0.760 |
Why?
| Extracellular Matrix | 5 | 2021 | 439 | 0.750 |
Why?
| Drug Resistance, Neoplasm | 2 | 2021 | 638 | 0.680 |
Why?
| Cell Line, Tumor | 10 | 2021 | 2751 | 0.610 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 225 | 0.600 |
Why?
| Lactation | 4 | 2022 | 149 | 0.600 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 193 | 0.580 |
Why?
| Mice | 17 | 2022 | 15052 | 0.540 |
Why?
| Neoplasm Metastasis | 5 | 2020 | 526 | 0.540 |
Why?
| NF-kappa B | 1 | 2019 | 639 | 0.520 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 50 | 0.520 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 863 | 0.510 |
Why?
| Biomarkers, Tumor | 2 | 2020 | 1048 | 0.500 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 400 | 0.490 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2020 | 50 | 0.470 |
Why?
| Pregnancy | 10 | 2024 | 5549 | 0.450 |
Why?
| Animals | 21 | 2022 | 32102 | 0.450 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2020 | 704 | 0.440 |
Why?
| Cell Movement | 6 | 2022 | 867 | 0.440 |
Why?
| Female | 25 | 2024 | 59913 | 0.400 |
Why?
| Fibrillar Collagens | 1 | 2011 | 12 | 0.390 |
Why?
| Carcinoma, Ductal | 1 | 2011 | 11 | 0.390 |
Why?
| Disease Models, Animal | 5 | 2020 | 3580 | 0.390 |
Why?
| Mice, Inbred BALB C | 3 | 2019 | 1168 | 0.360 |
Why?
| Neoplasm Invasiveness | 5 | 2020 | 445 | 0.340 |
Why?
| Antigens, Differentiation, Myelomonocytic | 2 | 2019 | 53 | 0.320 |
Why?
| Humans | 28 | 2024 | 115589 | 0.290 |
Why?
| Cell Survival | 2 | 2021 | 1024 | 0.290 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4773 | 0.280 |
Why?
| Membrane Glycoproteins | 2 | 2019 | 431 | 0.280 |
Why?
| Prognosis | 4 | 2020 | 3339 | 0.270 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2007 | 139 | 0.260 |
Why?
| Mice, SCID | 2 | 2020 | 321 | 0.260 |
Why?
| Cell Transformation, Neoplastic | 2 | 2021 | 314 | 0.260 |
Why?
| Apoptosis | 2 | 2020 | 2377 | 0.250 |
Why?
| Mice, Knockout | 3 | 2022 | 2604 | 0.240 |
Why?
| Mice, Inbred NOD | 3 | 2021 | 560 | 0.240 |
Why?
| Head and Neck Neoplasms | 2 | 2020 | 425 | 0.220 |
Why?
| Celecoxib | 2 | 2014 | 38 | 0.220 |
Why?
| Disease-Free Survival | 2 | 2021 | 621 | 0.210 |
Why?
| Immune Evasion | 1 | 2022 | 47 | 0.210 |
Why?
| Disease Progression | 3 | 2020 | 2418 | 0.200 |
Why?
| Receptors, CXCR3 | 1 | 2022 | 15 | 0.200 |
Why?
| Chemokine CXCL9 | 1 | 2022 | 22 | 0.200 |
Why?
| Integrin alpha6 | 1 | 2021 | 8 | 0.200 |
Why?
| Caspase 7 | 1 | 2021 | 22 | 0.200 |
Why?
| Immunohistochemistry | 2 | 2019 | 1642 | 0.200 |
Why?
| Chemokine CXCL10 | 1 | 2022 | 35 | 0.200 |
Why?
| Integrin beta1 | 1 | 2021 | 17 | 0.200 |
Why?
| Gene Knockdown Techniques | 2 | 2020 | 302 | 0.190 |
Why?
| Fibronectins | 2 | 2020 | 108 | 0.190 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 27 | 0.180 |
Why?
| Mammals | 1 | 2022 | 251 | 0.180 |
Why?
| Caspase 3 | 1 | 2021 | 237 | 0.180 |
Why?
| Melanoma, Experimental | 1 | 2022 | 118 | 0.180 |
Why?
| Cytoskeletal Proteins | 1 | 2021 | 145 | 0.180 |
Why?
| Actin Cytoskeleton | 1 | 2021 | 93 | 0.180 |
Why?
| Hyaluronan Receptors | 1 | 2020 | 91 | 0.180 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2022 | 192 | 0.170 |
Why?
| Lymphatic Metastasis | 3 | 2019 | 276 | 0.170 |
Why?
| Models, Biological | 3 | 2019 | 1646 | 0.170 |
Why?
| Adipocytes | 1 | 2021 | 188 | 0.170 |
Why?
| Pyrazoles | 2 | 2014 | 362 | 0.170 |
Why?
| Signal Transduction | 5 | 2022 | 4541 | 0.170 |
Why?
| Maternal Age | 1 | 2020 | 117 | 0.170 |
Why?
| Kaplan-Meier Estimate | 2 | 2020 | 815 | 0.170 |
Why?
| Sulfonamides | 2 | 2014 | 447 | 0.170 |
Why?
| Estrogens | 2 | 2020 | 315 | 0.170 |
Why?
| Enzyme Activation | 1 | 2021 | 793 | 0.170 |
Why?
| Extracellular Vesicles | 1 | 2020 | 83 | 0.170 |
Why?
| Collagen | 2 | 2013 | 415 | 0.170 |
Why?
| Genes, Reporter | 1 | 2019 | 257 | 0.160 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2019 | 64 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 930 | 0.160 |
Why?
| Actins | 1 | 2021 | 383 | 0.160 |
Why?
| Tumor Cells, Cultured | 1 | 2020 | 850 | 0.160 |
Why?
| Phosphorylation | 2 | 2021 | 1571 | 0.160 |
Why?
| Crosses, Genetic | 1 | 2018 | 141 | 0.160 |
Why?
| Cell Proliferation | 3 | 2020 | 2194 | 0.160 |
Why?
| Integrins | 1 | 2018 | 79 | 0.150 |
Why?
| Protein Binding | 2 | 2022 | 1917 | 0.150 |
Why?
| B7-H1 Antigen | 1 | 2019 | 139 | 0.150 |
Why?
| RNA, Small Interfering | 1 | 2020 | 544 | 0.150 |
Why?
| Podosomes | 1 | 2016 | 3 | 0.140 |
Why?
| Neoplastic Stem Cells | 1 | 2020 | 331 | 0.140 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 45 | 0.140 |
Why?
| Survival Rate | 1 | 2020 | 1650 | 0.140 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 63 | 0.130 |
Why?
| Genetic Pleiotropy | 1 | 2016 | 29 | 0.130 |
Why?
| Protein Kinase Inhibitors | 1 | 2021 | 790 | 0.130 |
Why?
| Melanoma | 1 | 2022 | 651 | 0.130 |
Why?
| Phenotype | 2 | 2021 | 2829 | 0.120 |
Why?
| Skin Neoplasms | 1 | 2022 | 761 | 0.120 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 693 | 0.120 |
Why?
| Blotting, Western | 3 | 2011 | 1153 | 0.110 |
Why?
| Dinoprostone | 1 | 2014 | 186 | 0.110 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2019 | 965 | 0.110 |
Why?
| Endothelial Cells | 1 | 2018 | 695 | 0.110 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2013 | 76 | 0.100 |
Why?
| Drug Design | 1 | 2013 | 156 | 0.100 |
Why?
| Hematopoietic Stem Cells | 1 | 2015 | 346 | 0.100 |
Why?
| Ibuprofen | 1 | 2011 | 73 | 0.090 |
Why?
| Time Factors | 4 | 2020 | 6165 | 0.090 |
Why?
| Risk | 2 | 2013 | 819 | 0.090 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2011 | 310 | 0.090 |
Why?
| Cohort Studies | 1 | 2020 | 4944 | 0.090 |
Why?
| BRCA1 Protein | 1 | 2010 | 57 | 0.090 |
Why?
| Mutation | 1 | 2019 | 3364 | 0.080 |
Why?
| Incidence | 2 | 2020 | 2335 | 0.080 |
Why?
| Macrophage Activation | 1 | 2010 | 165 | 0.080 |
Why?
| Stromal Cells | 1 | 2009 | 97 | 0.080 |
Why?
| Analysis of Variance | 1 | 2011 | 1227 | 0.080 |
Why?
| Extracellular Matrix Proteins | 1 | 2009 | 127 | 0.080 |
Why?
| Tamoxifen | 1 | 2009 | 192 | 0.080 |
Why?
| Gonadal Steroid Hormones | 1 | 2009 | 124 | 0.070 |
Why?
| Insulin-Like Growth Factor I | 1 | 2010 | 281 | 0.070 |
Why?
| Restriction Mapping | 1 | 2007 | 77 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 350 | 0.070 |
Why?
| Disease Susceptibility | 1 | 2009 | 316 | 0.070 |
Why?
| Estradiol | 1 | 2010 | 452 | 0.070 |
Why?
| Cloning, Molecular | 1 | 2007 | 523 | 0.070 |
Why?
| Cell Line | 2 | 2010 | 2651 | 0.060 |
Why?
| Immunotherapy | 2 | 2022 | 479 | 0.060 |
Why?
| Young Adult | 3 | 2020 | 10470 | 0.060 |
Why?
| Recombinant Fusion Proteins | 1 | 2007 | 616 | 0.060 |
Why?
| Adult | 6 | 2020 | 30719 | 0.060 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2020 | 332 | 0.060 |
Why?
| Base Sequence | 1 | 2007 | 2114 | 0.050 |
Why?
| Neoplasms | 1 | 2016 | 2118 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2790 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 2013 | 1893 | 0.050 |
Why?
| Cell Cycle Proteins | 2 | 2020 | 553 | 0.050 |
Why?
| Stress Fibers | 1 | 2021 | 16 | 0.050 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 156 | 0.050 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 111 | 0.050 |
Why?
| Focal Adhesions | 1 | 2021 | 42 | 0.050 |
Why?
| Tumor Burden | 1 | 2022 | 261 | 0.050 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 23 | 0.050 |
Why?
| Feedback, Physiological | 1 | 2020 | 73 | 0.040 |
Why?
| Kidney | 1 | 2007 | 1207 | 0.040 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.040 |
Why?
| SOXB1 Transcription Factors | 1 | 2020 | 60 | 0.040 |
Why?
| Proteomics | 2 | 2020 | 859 | 0.040 |
Why?
| Cell Adhesion | 1 | 2020 | 433 | 0.040 |
Why?
| Cell Communication | 1 | 2020 | 282 | 0.040 |
Why?
| Hyaluronic Acid | 1 | 2020 | 190 | 0.040 |
Why?
| Survival Analysis | 1 | 2022 | 1219 | 0.040 |
Why?
| Parity | 1 | 2019 | 99 | 0.040 |
Why?
| Ki-67 Antigen | 1 | 2019 | 104 | 0.040 |
Why?
| Rats | 3 | 2013 | 5034 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 374 | 0.040 |
Why?
| Global Health | 1 | 2020 | 290 | 0.040 |
Why?
| Monocytes | 1 | 2020 | 507 | 0.040 |
Why?
| Neoplasm Proteins | 1 | 2020 | 385 | 0.040 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.030 |
Why?
| Breast Feeding | 1 | 2020 | 370 | 0.030 |
Why?
| Lymph Nodes | 1 | 2019 | 423 | 0.030 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 117 | 0.030 |
Why?
| Protein Domains | 1 | 2016 | 209 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2019 | 1178 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2010 | 2262 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2020 | 1536 | 0.030 |
Why?
| Bone Marrow | 1 | 2015 | 249 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3022 | 0.030 |
Why?
| Risk Factors | 2 | 2019 | 8697 | 0.030 |
Why?
| Middle Aged | 3 | 2020 | 26998 | 0.030 |
Why?
| Cadherins | 1 | 2013 | 175 | 0.030 |
Why?
| Liver | 1 | 2020 | 1690 | 0.030 |
Why?
| MicroRNAs | 1 | 2016 | 607 | 0.020 |
Why?
| Weaning | 1 | 2010 | 48 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2010 | 58 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2013 | 1087 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2010 | 154 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2010 | 136 | 0.020 |
Why?
| Matrix Metalloproteinases | 1 | 2010 | 87 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2013 | 1440 | 0.020 |
Why?
| Biomarkers | 2 | 2010 | 3467 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 165 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 398 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 552 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 139 | 0.020 |
Why?
| Protein Transport | 1 | 2010 | 400 | 0.020 |
Why?
| Cytokines | 1 | 2015 | 1853 | 0.020 |
Why?
| Mice, Nude | 1 | 2009 | 639 | 0.020 |
Why?
| Cell Cycle | 1 | 2010 | 546 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2010 | 645 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1243 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2009 | 344 | 0.020 |
Why?
| Fibroblasts | 1 | 2009 | 839 | 0.010 |
Why?
| Adolescent | 1 | 2020 | 17890 | 0.010 |
Why?
| Cells, Cultured | 1 | 2010 | 3914 | 0.010 |
Why?
| Retrospective Studies | 1 | 2013 | 12608 | 0.010 |
Why?
| Male | 1 | 2020 | 55949 | 0.010 |
Why?
| Aged | 1 | 2010 | 19250 | 0.010 |
Why?
|
|
Lyons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|